Vanguard Emerging Markets Stock Index Fund ETF (VWO) Stock Price Today
Aura AI Summary
Key Stats
- $168.50BMarket Cap
- 5,654,578Volume
- -Sector
- $61.4452W High
- $52.4252W Low
- 136 DaysTypical Hold Time
- -Enterprise Value
- -Div Yield
- 23% Sell | 77% BuyTrading Activity
Track Vanguard Emerging Markets Stock Index Fund ETF (VWO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Vanguard Emerging Markets Stock Index Fund ETF has traded between a low of $52.42 and a high of $61.44, highlighting its annual price range. Buy and sell Vanguard Emerging Markets Stock Index Fund ETF shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Vanguard Emerging Markets Stock Index Fund ETF
The fund employs an indexing investment approach designed to track the performance of the FTSE Emerging Markets All Cap China A Inclusion Index. It invests by sampling the index, meaning that it holds a broadly diversified collection of securities that, in the aggregate, approximates the index in terms of key characteristics.
Most Recent News
UBS Group AG surpasses 5% ownership in Bang & Olufsen shares as of October 9, 2026
UBS Group AG has officially notified that it holds 7,768,727 shares in Bang & Olufsen A/S, representing 5.27% of the company's total share capital and voting rights as of October 9, 2026. This disclosure is made in compliance with the Danish Capital ...
FDA approves Roche’s Enspryng as first at-home treatment for thyroid eye disease
The FDA has approved Roche's Enspryng (satralizumab) as the first and only at-home subcutaneous treatment for adults with thyroid eye disease (TED). This approval follows positive results from Phase III SatraGO-2 trials showing significant reductions...
IP Group invests £4m as Microbiotica raises £36m to advance ulcerative colitis drug to Phase 2 trials
IP Group PLC has invested £4 million in a £36 million Series C funding round for Microbiotica, supporting the development of its ulcerative colitis treatment, MB310. The funding, led by British Business Bank, will enable Microbiotica to progress MB31...
People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.